Balance Therapeutics balance-therapeutics.com


Public lists: Pharma Startups (4732)

Balance Therapeutics is a pharmaceutical research and development company focused on developing therapeutics to address conditions of intellectual disability, most centrally, Down Syndrome and and other genetic diseases. The Company's pharmacological approach, based on technology licensed from Stanford University, hypothesizes that restoring the proper balance between inhibition and excitation at the neuronal synapse by antagonizing excessive inhibitory circuits could result in the appropriate ...Show all

Balance Therapeutics is a pharmaceutical research and development company focused on developing therapeutics to address conditions of intellectual disability, most centrally, Down Syndrome and and other genetic diseases. The Company's pharmacologica...Show all

Company (Alive / Active)

Phone: 650-741-9100

Fax:

1250 Bayhill Drive
#125
San Bruno, 94066
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Balance Therapeutics $21.2M May 19, 2015

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Balance Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
OrbiMed AdvisorsVenture CapitalNew York, New York, United StatesOther Investors
Pappas VenturesVenture CapitalDurham, North Carolina, United StatesSeries A - II, Series A
Undisclosed InvestorsOtherUnattributed
Mohr Davidow VenturesVenture CapitalMenlo Park, California, United StatesSeries A - II, Series A, Seed VC
See all 4 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Deuterated pentylenetetrazoles for improving cognitive function Aug 24, 2016 Apr 24, 2018 Patent